WO1995003084A3 - Extracorporeal affinity adsorption devices - Google Patents

Extracorporeal affinity adsorption devices Download PDF

Info

Publication number
WO1995003084A3
WO1995003084A3 PCT/US1994/008043 US9408043W WO9503084A3 WO 1995003084 A3 WO1995003084 A3 WO 1995003084A3 US 9408043 W US9408043 W US 9408043W WO 9503084 A3 WO9503084 A3 WO 9503084A3
Authority
WO
WIPO (PCT)
Prior art keywords
extracorporeal
diseases
affinity adsorption
adsorption devices
immunotherapy
Prior art date
Application number
PCT/US1994/008043
Other languages
French (fr)
Other versions
WO1995003084A2 (en
Inventor
Meir Strahilevitz
Original Assignee
Meir Strahilevitz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meir Strahilevitz filed Critical Meir Strahilevitz
Priority to DE69435170T priority Critical patent/DE69435170D1/en
Priority to AU74725/94A priority patent/AU7472594A/en
Priority to US08/464,898 priority patent/US6039946A/en
Priority to EP94924465A priority patent/EP0710135B1/en
Publication of WO1995003084A2 publication Critical patent/WO1995003084A2/en
Publication of WO1995003084A3 publication Critical patent/WO1995003084A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3475—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate with filtrate treatment agent in the same enclosure as the membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/362—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits changing physical properties of target cells by binding them to added particles to facilitate their subsequent separation from other cells, e.g. immunoaffinity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Abstract

Extracorporeal affinity adsorption devices which are aimed at the substantial removal of two or more compounds that are etiological in the pathogenesis of diseases in man, provide effective therapeutic intervention means for these diseases. The devices are particularly suitable for the treatment of atherosclerosis, cancer, degenerative and autoimmune diseases. Extracorporeal chelation and immunotherapy for artherosclerosis, extracorporeal chelation treatment with on-line regeneration or replacement of chelant, extracorporeal immunotherapy with antibody fragments, and extracorporeal immunoadsorption utilizing antibodies bound to Protein A are also disclosed.
PCT/US1994/008043 1993-07-23 1994-07-20 Extracorporeal affinity adsorption devices WO1995003084A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DE69435170T DE69435170D1 (en) 1993-07-23 1994-07-20 Extrakorporeal devices for adsorption by affinity
AU74725/94A AU7472594A (en) 1993-07-23 1994-07-20 Extracorporeal affinity adsorption devices
US08/464,898 US6039946A (en) 1993-07-23 1994-07-20 Extracorporeal affinity adsorption devices
EP94924465A EP0710135B1 (en) 1993-07-23 1994-07-20 Extracorporeal Affinity Adsorption Devices

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/097,378 1993-07-23
US08/097,378 US5753227A (en) 1993-07-23 1993-07-23 Extracorporeal affinity adsorption methods for the treatment of atherosclerosis, cancer, degenerative and autoimmune diseases

Publications (2)

Publication Number Publication Date
WO1995003084A2 WO1995003084A2 (en) 1995-02-02
WO1995003084A3 true WO1995003084A3 (en) 1995-03-16

Family

ID=22263054

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1994/008043 WO1995003084A2 (en) 1993-07-23 1994-07-20 Extracorporeal affinity adsorption devices

Country Status (6)

Country Link
US (6) US5753227A (en)
EP (1) EP0710135B1 (en)
AU (1) AU7472594A (en)
DE (1) DE69435170D1 (en)
IL (1) IL110382A (en)
WO (1) WO1995003084A2 (en)

Families Citing this family (139)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4375414A (en) * 1971-05-20 1983-03-01 Meir Strahilevitz Immunological methods for removing species from the blood circulatory system and devices therefor
US5919369A (en) * 1992-02-06 1999-07-06 Hemocleanse, Inc. Hemofiltration and plasmafiltration devices and methods
US5753227A (en) * 1993-07-23 1998-05-19 Strahilevitz; Meir Extracorporeal affinity adsorption methods for the treatment of atherosclerosis, cancer, degenerative and autoimmune diseases
AUPN030794A0 (en) 1994-12-22 1995-01-27 Aruba International Pty Ltd Discontinuous plasma or serum delipidation
US7166295B1 (en) * 1995-05-26 2007-01-23 Meir Strahilevitz Methods of treatment and diagnostic visualization, particularly in cancer
US5868936A (en) * 1996-06-20 1999-02-09 Baxter International Inc. Affinity membrane system and method of using same
EP0834329A1 (en) * 1996-09-09 1998-04-08 Kaneka Corporation Method and apparatus for treating blood
US6245038B1 (en) * 1997-01-07 2001-06-12 Helmut Borberg Method for treatment of ophthalmological diseases
US6627151B1 (en) * 1997-06-13 2003-09-30 Helmut Borberg Method for treatment diseases associated with a deterioration of the macrocirculation, microcirculation and organ perfusion
US20020197250A1 (en) * 2001-04-10 2002-12-26 Renal Tech International Biocompatible devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood
US20020159995A1 (en) * 1997-07-30 2002-10-31 Renal Tech International Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood, generated as a result of extracorporeal blood processing
US20020198487A1 (en) * 2001-04-10 2002-12-26 Renal Tech International Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in physiologic fluids
US20020197249A1 (en) * 2001-04-10 2002-12-26 Renal Tech International Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood products
US8329388B2 (en) * 1997-07-30 2012-12-11 Cytosorbents, Inc. Biocompatible devices, systems, and methods for reducing levels of proinflammatory of antiinflammatory stimulators or mediators in the blood
US8197430B1 (en) * 1998-05-22 2012-06-12 Biopheresis Technologies, Inc. Method and system to remove cytokine inhibitor in patients
US6620382B1 (en) * 1998-05-22 2003-09-16 Biopheresis Technologies, Llc. Method and compositions for treatment of cancers
US6287516B1 (en) * 1998-07-10 2001-09-11 Immunocept, L.L.C. Hemofiltration systems, methods, and devices used to treat inflammatory mediator related disease
US20040199099A1 (en) * 1998-07-10 2004-10-07 Matson James R Hemofiltration systems, methods and devices used to treat inflammatory mediator related disease
EP1595948A3 (en) * 1999-03-05 2006-03-01 Mitsubishi Rayon Co., Ltd. Carriers having biological substance
WO2000066198A1 (en) * 1999-04-30 2000-11-09 Hemex, Inc. Method for removing heavy metals from bone
WO2000074824A1 (en) * 1999-06-03 2000-12-14 Advanced Extravascular Systems One step removal of unwanted molecules from circulating blood
US6464976B1 (en) 1999-09-07 2002-10-15 Canji, Inc. Methods and compositions for reducing immune response
US6379708B1 (en) * 1999-11-20 2002-04-30 Cytologic, Llc Method for enhancing immune responses in mammals
US6736972B1 (en) 2000-03-24 2004-05-18 Immunocept, L.L.C. Method and system for providing therapeutic agents with hemofiltration for reducing inflammatory mediator related diseases
US7291122B2 (en) * 2000-03-24 2007-11-06 Immunocept, L.L.C. Hemofiltration methods for treatment of diseases in a mammal
AU2001259469A1 (en) * 2000-05-05 2001-11-20 Hemocleanse, Inc. Use of magnetic particles or other particles having relatively high density in afluid for mixing and/or leak detection
US8865172B2 (en) 2000-05-08 2014-10-21 Advanced Extravascular Systems, Inc. Method for reducing the number of unwanted molecules in bodily fluids
US6787040B2 (en) * 2000-05-16 2004-09-07 Immunocept, L.L.C. Method and system for colloid exchange therapy
US7407663B2 (en) 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified immunodeficiency virus particles
US7439052B2 (en) * 2000-06-29 2008-10-21 Lipid Sciences Method of making modified immunodeficiency virus particles
US7407662B2 (en) * 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified viral particles with immunogenic properties and reduced lipid content
US20090017069A1 (en) * 2000-06-29 2009-01-15 Lipid Sciences, Inc. SARS Vaccine Compositions and Methods of Making and Using Them
AUPQ846900A0 (en) * 2000-06-29 2000-07-27 Aruba International Pty Ltd A vaccine
DE50105716D1 (en) * 2000-09-12 2005-04-28 Max Planck Gesellschaft HIGH-TEMPERATURE STABLE SILICON-BOROCARBIDE NITRIDE CERAMICS FROM SILYL ALKYLBORAZINES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
GB0103766D0 (en) * 2001-02-15 2001-04-04 Affitech As Diagnostic
US6706008B2 (en) 2001-03-06 2004-03-16 Baxter International Inc. Automated system and method for withdrawing compounds from blood
US6582386B2 (en) 2001-03-06 2003-06-24 Baxter International Inc. Multi-purpose, automated blood and fluid processing systems and methods
US6884228B2 (en) 2001-03-06 2005-04-26 Baxter International Inc. Automated system adaptable for use with different fluid circuits
US6878127B2 (en) * 2001-04-10 2005-04-12 Renaltech International, Llc Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood
US20020197252A1 (en) * 2001-04-10 2002-12-26 Renal Tech International Selective adsorption devices and systems
EP1412045A4 (en) * 2001-06-25 2007-05-02 Lipid Sciences Inc Systems and methods using a solvent for the removal of lipids from fluids
AU2002322284A1 (en) * 2001-06-25 2003-01-08 Lipid Sciences, Inc. Systems and methods using multiple solvents for the removal of lipids from fluids
US6991727B2 (en) * 2001-06-25 2006-01-31 Lipid Sciences, Inc. Hollow fiber contactor systems for removal of lipids from fluids
US20060060520A1 (en) * 2001-06-25 2006-03-23 Bomberger David C Systems and methods using a solvent for the removal of lipids from fluids
FR2826975B1 (en) * 2001-07-09 2004-06-04 Bio Merieux USE OF OXIDIZED LIPOPROTEINS FOR OBTAINING THE DIFFERENTIATION OF MONOCYTES IN MATURE DENDRITIC CELLS
EP1420641A4 (en) * 2001-08-01 2005-05-25 Anil K Chauhan Immune complexes
EP1575507A2 (en) * 2002-04-02 2005-09-21 Scantibodies Laboratory, Inc. Methods and devices for treating severe peripheral bacterial infections
US7425331B2 (en) * 2002-04-10 2008-09-16 Protalex, Inc. Protein A methods of use
US7211258B2 (en) * 2002-04-10 2007-05-01 Protalex, Inc. Protein A compositions and methods of use
EP1507557A4 (en) * 2002-04-23 2006-06-14 Meir Strahilevitz Methods and devices for targeting a site in a mammal and for removing species from a mammal
US7455771B2 (en) 2002-05-14 2008-11-25 Hepa Wash Gmbh Means for removing protein-bound substances
EP1362605A1 (en) * 2002-05-14 2003-11-19 Bernhard Dr. Kreymann Dialysis apparatus to remove protein bound substances
US20040102732A1 (en) * 2002-06-19 2004-05-27 Morteza Naghavi Dialysis system for treatment of vulnerable patients and methods of use
JP2005535394A (en) * 2002-08-13 2005-11-24 アルビオス テクノロジーズ インコーポレーティッド Selective plasma exchange method
KR100459432B1 (en) * 2002-08-21 2004-12-03 엘지전자 주식회사 Method for processing handover in mobile communication system
US20040106556A1 (en) * 2002-08-26 2004-06-03 Yanhong Zhu Method of treating and preventing alzheimer disease through administration of delipidated protein and lipoprotein particles
WO2004050023A2 (en) 2002-11-27 2004-06-17 Dmi Biosciences, Inc. Treatment of diseases and conditions mediated by increased phosphorylation
WO2004071446A2 (en) * 2003-02-12 2004-08-26 Chauhan Anil K Immune complexes
US7207964B2 (en) * 2003-03-17 2007-04-24 Hemavation, Llc Apparatus and method for down-regulating immune system mediators in blood
US7229427B2 (en) * 2003-03-17 2007-06-12 Hemavation Irradiation and filter device for treatment of blood
US20040185426A1 (en) * 2003-03-17 2004-09-23 Mallett Scott R. Ultraviolet light and filter apparatus for treatment of blood
US7201730B2 (en) 2003-03-17 2007-04-10 Hemavation, Llc Device and method for reducing inflammatory mediators in blood
US20040185041A1 (en) * 2003-03-17 2004-09-23 Henna Vation, Llc Method for extracorporeal treatment of blood
US20040186407A1 (en) * 2003-03-17 2004-09-23 Kimberly Walker Concentrator and filter apparatus for treatment of blood
US20040182784A1 (en) * 2003-03-17 2004-09-23 Walker Kimberly A. Concentrator and filter based blood treatment system
US20040186412A1 (en) * 2003-03-17 2004-09-23 Mallett Scott R. Extracorporeal blood treatment system using ultraviolet light and filters
US20040182783A1 (en) * 2003-03-17 2004-09-23 Walker Kimberly A. Filter and concentrator device for treatment of blood
US7341843B2 (en) * 2003-04-11 2008-03-11 Allergan, Inc. Botulinum toxin A peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy
US20080171347A1 (en) * 2003-04-11 2008-07-17 Atassi M Zouhair Determining and reducing immunoresistance to botulinum toxin therapy using botulinum toxin a peptides
PT2368565E (en) * 2003-07-03 2015-10-19 Hdl Therapeutics Inc Enrichment of pre-beta high density lipoproteins
US7393826B2 (en) * 2003-07-03 2008-07-01 Lipid Sciences, Inc. Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
US6960803B2 (en) * 2003-10-23 2005-11-01 Silicon Storage Technology, Inc. Landing pad for use as a contact to a conductive spacer
CN2698358Y (en) * 2004-04-06 2005-05-11 上海江夏血液技术有限公司 Blood filtering device
CA2560882A1 (en) * 2004-04-26 2005-11-03 Teva Pharmaceutical Industries Ltd. Crystalline forms of fexofenadine hydrochloride and processes for their preparation
AU2005240082B2 (en) * 2004-04-30 2009-07-23 Innatus Corporation Method and system to remove soluble TNFR1,TNFR2, and IL2 in patients
WO2006012884A1 (en) * 2004-07-30 2006-02-09 Adexter Technology Limited Device and method for isolating cells, bioparticles and/or molecules from liquids designed to be used for the treatment of human diseases
WO2007001332A2 (en) 2004-08-04 2007-01-04 University Of Massachusetts Anti-pathogen immunoadhesins
US20060068454A1 (en) * 2004-09-27 2006-03-30 Sysmex Corporation Method of inactivating blood coagulation factor and blood coagulation factor-inactivated sample
US20070258992A1 (en) * 2004-10-06 2007-11-08 Atassi M Zouhair Determining and Reducing Immunoresistance to Botulinum Toxin Therapy Using Botulinum Toxin a Peptides
US7569353B2 (en) * 2004-11-04 2009-08-04 Quest Diagnostics Investments Incorporated Myeloperoxidase detection in diagnosis and prognosis of hematopoietic disorders
US20060147536A1 (en) * 2004-12-30 2006-07-06 Fiore Robert A Method for removing fluids containing dissolved or suspended carbohydrates, lipids, metals, salts, and/or toxins from biological systems
EP1951336A2 (en) * 2005-07-18 2008-08-06 The Trustees Of Boston University Method to inhibit proliferation and growth of metastases
US20070065514A1 (en) * 2005-09-22 2007-03-22 Howell Mark D Method for enhancing immune responses in mammals
KR101397386B1 (en) 2005-12-13 2014-05-26 엑스테라 메디컬 코퍼레이션 Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood
DE102006012024A1 (en) * 2006-03-14 2007-09-20 Adexter Gmbh Regenerable filter for extracorporeal treatment of particle-containing liquids and their use
US7670788B2 (en) * 2006-06-01 2010-03-02 Allergan, Inc. Determining and reducing immunoresistance to a Botulinum toxin therapy using Botulinum toxin B peptides
US7855268B2 (en) * 2006-06-01 2010-12-21 Allergan, Inc. Tolerogizing compositions comprising botulinum toxin type B peptides
WO2008026953A1 (en) * 2006-08-28 2008-03-06 Akademia Medyczna Im. Piastow Slaskich We Wroclawiu A system and method for the extra-corporeal purification of blood of pathogenic enzymes
WO2008026667A1 (en) 2006-08-31 2008-03-06 Toray Industries, Inc. Adsorption carrier containing composite fiber
US20080075690A1 (en) * 2006-09-22 2008-03-27 Mark Douglas Howell Method for enhancing immune responses in mammals
US8211310B2 (en) 2006-11-20 2012-07-03 Cytosorbents, Inc. Size-selective polymer system
US9604196B2 (en) 2006-11-20 2017-03-28 Cytosorbent, Inc. Size-selective hemocompatible polymer system
US7875182B2 (en) 2006-11-20 2011-01-25 Cytosorbents, Inc. Size-selective hemoperfusion polymeric adsorbents
EP2002855B1 (en) * 2007-06-14 2012-07-11 RenApta B.V. Artificial kidney
EP2244662B1 (en) * 2008-01-28 2021-09-29 Implantica Patent Ltd. Blood clot removal device and system
US8317737B2 (en) * 2009-02-25 2012-11-27 The Invention Science Fund I, Llc Device for actively removing a target component from blood or lymph of a vertebrate subject
US8246565B2 (en) * 2009-02-25 2012-08-21 The Invention Science Fund I, Llc Device for passively removing a target component from blood or lymph of a vertebrate subject
US8430831B2 (en) 2009-02-25 2013-04-30 The Invention Science Fund I, Llc Device, system, and method for controllably reducing inflammatory mediators in a subject
US9216386B2 (en) * 2009-03-17 2015-12-22 Marv Enterprises, LLC Sequential extracorporeal treatment of bodily fluids
JP5925693B2 (en) 2009-12-01 2016-05-25 エクステラ・メディカル・コーポレーション Method for removing cytokines from blood using surface-immobilized polysaccharides
AU2010341703B2 (en) * 2009-12-08 2016-01-21 The Board Of Trustees Of The University Of Illinois Stem cell immune modulation methods of use and apparatus
US20110295175A1 (en) * 2010-03-16 2011-12-01 Marv Enterprises Llc Sequential Extracoporeal Treatment of Bodily Fluids
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
EP3184131B1 (en) 2011-04-13 2022-05-04 Fenwal, Inc. Centrifugation system with red blood cell barrier
CN103476484B (en) 2011-04-13 2016-11-09 汾沃有限公司 For using and controlling the system and method for the automatic segregator with adsorption column
US20140193514A1 (en) * 2011-08-19 2014-07-10 Marv Enterprises Method for the Treatment of Cancer
EP2758780A4 (en) * 2011-09-22 2015-09-16 Marv Entpr Llc Method for the treatment of multiple sclerosis
SE1200356A1 (en) 2011-10-30 2013-05-01 Kurt Nilsson Polymer-based product and use
US20150027950A1 (en) * 2012-03-27 2015-01-29 Marv Enterprises, LLC Treatment for atherosclerosis
WO2013177096A1 (en) * 2012-05-22 2013-11-28 Felder Mitchell S A method for the treatment of cancer
WO2013181016A2 (en) * 2012-05-27 2013-12-05 Felder Mitchell S Treatment for the rapid amelioration of clinical depression
EP2861273B1 (en) * 2012-06-13 2017-08-23 ExThera Medical Corporation Use of heparin and carbohydrates to treat cancer
US9717841B2 (en) 2012-09-11 2017-08-01 Gary L. McNeil Closed-circuit device and methods for isolation, modification, and re-administration of specific constituents from a biological fluid source
EP3620218A1 (en) 2013-06-24 2020-03-11 ExThera Medical Corporation Blood filtration system containing mannose coated substrate
JP6806563B2 (en) 2013-11-08 2021-01-06 エクステラ・メディカル・コーポレーション Diagnosis of infectious diseases using adsorption medium
MX2016013873A (en) 2014-04-24 2017-03-09 Exthera Medical Corp Method for removing bacteria from blood using high flow rate.
WO2015171272A1 (en) * 2014-05-06 2015-11-12 Felder Mitchell S Method for treating muscular dystrophy
EP2987512B1 (en) 2014-08-21 2017-03-22 Fenwal, Inc. Parallel processing of fluid components
ES2821698T3 (en) 2014-09-22 2021-04-27 Exthera Medical Corp Portable hemoperfusion device
WO2017075189A1 (en) 2015-10-27 2017-05-04 University Of Massachusetts Factor h-fc immunotherapy
WO2017084683A1 (en) 2015-11-20 2017-05-26 Hepa Wash Gmbh Method for extracorporeal lung support
WO2017084682A1 (en) 2015-11-20 2017-05-26 Hepa Wash Gmbh Method for extracorporeal carbon dioxide removal
US11383015B2 (en) 2016-01-11 2022-07-12 Fenwal, Inc. System and method for plasma purification prior to mononuclear cell collection
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
US10786615B2 (en) 2016-03-02 2020-09-29 Exthera Medical Corporation Method for treating drug intoxication
PL3429657T3 (en) 2016-03-14 2022-08-22 Advitos Gmbh Systems or apparatuses for performing dialysis
US10858422B2 (en) 2016-05-31 2020-12-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
WO2017210360A1 (en) 2016-05-31 2017-12-07 Cardiovax, Llc Methods for diagnosing and treating systemic lupus erythematosus
HUE064189T2 (en) 2016-07-28 2024-02-28 Captec Medical Kft Flow capture device for removing cells from blood
KR20200011461A (en) 2017-05-22 2020-02-03 아드비토스 게엠베하 Carbon Dioxide Removal Method and System
CA3083194A1 (en) 2017-11-22 2019-05-31 Hdl Therapeutics, Inc. Systems and methods for priming fluid circuits of a plasma processing system
CA3087207A1 (en) 2017-12-28 2019-07-04 Hdl Therapeutics, Inc. Methods for preserving and administering pre-beta high density lipoprotein extracted from human plasma
ES2722802B2 (en) * 2018-02-14 2019-12-18 Fund De Neurociencias DEVICE FOR THE SELECTIVE ELIMINATION OF MOLECULES OF FABRICS OR FLOWS
FR3091999A1 (en) * 2019-01-25 2020-07-31 Mexbrain Device for the joint extraction of a metal cation and a target molecule
WO2020176683A1 (en) * 2019-02-26 2020-09-03 Qualigen Inc. Whole blood treatment device and methods of removing target agents from whole blood
EP3705146A3 (en) 2019-03-05 2020-11-25 Fenwal, Inc. Collection of mononuclear cells and peripheral blood stem cells
US11224858B1 (en) 2020-10-01 2022-01-18 Immunicom, Inc. Reduced leaching of a ligand
KR20230074799A (en) 2020-10-01 2023-05-31 이뮤니컴 인코포레이티드 Reduced leaching of ligands
ES2940917B2 (en) * 2023-02-22 2023-11-30 Tecnic Biotech S L An apheresis filter and a method for the removal of residual platinum in blood

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4375414A (en) * 1971-05-20 1983-03-01 Meir Strahilevitz Immunological methods for removing species from the blood circulatory system and devices therefor
US4612122A (en) * 1981-06-29 1986-09-16 Clara Ambrus Removing heavy metal ions from blood
US4770784A (en) * 1985-11-29 1988-09-13 The Standard Oil Company Scrubbing process for high feed concentrations
US5211850A (en) * 1991-07-26 1993-05-18 Research Medical, Inc. Plasma filter sorbent system for removal of components from blood

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3453194A (en) * 1966-08-03 1969-07-01 Dow Corning Anticoagulant surfaces produced by radiation grafting heparin to a silicone substrate
US4228015A (en) * 1979-01-29 1980-10-14 Baxter Travenol Laboratories, Inc. Plasma treatment apparatus
US4215688A (en) * 1979-02-09 1980-08-05 Baxter Travenol Laboratories, Inc. Apparatus for the extracorporeal treatment of disease
US4362155A (en) * 1981-03-24 1982-12-07 Skurkovich Simon V Method and apparatus for the treatment of autoimmune and allergic diseases
US4714556A (en) * 1981-06-29 1987-12-22 Ambrus Clara M Blood purification
US5091091A (en) * 1981-11-06 1992-02-25 Terman David S Protein A perfusion and post perfusion drug infusion
US4637880A (en) * 1981-11-30 1987-01-20 Cordis Laboratories, Inc. Apparatus and method for therapeutic immunodepletion
US4737544A (en) * 1982-08-12 1988-04-12 Biospecific Technologies, Inc. Biospecific polymers
US4627915A (en) * 1983-04-06 1986-12-09 Asahi Kasei Kogyo Kabushiki Kaisha Absorbent of autoantibody and immune complexes, adsorbing device and blood purifying apparatus comprising the same
US4551435A (en) * 1983-08-24 1985-11-05 Immunicon, Inc. Selective removal of immunospecifically recognizable substances from solution
US4614513A (en) * 1984-08-13 1986-09-30 Fred Hutchinson Cancer Research Center Method and apparatus for treatment to remove immunoreactive substances from blood
SE459503B (en) * 1985-05-03 1989-07-10 Excorim Kommanditbolag HYBRID DNA MOLECULE CONTAINING DNA SEQUENCE CODING FOR PROTEIN G AND PROCEDURE FOR PRODUCING PROTEIN G
US5061237A (en) * 1985-07-02 1991-10-29 Cytomed Medizintechnik Gmbh Method of purifying whole blood
US5782792A (en) * 1986-11-21 1998-07-21 Cypress Bioscience, Inc. Method for treatment of rheumatoid arthritis
EP0269279A3 (en) 1986-11-21 1988-09-14 Imre Corporation Extracorporeal removal of immunoglobulin-g and circulating immune complexes
DE3705637A1 (en) * 1987-02-21 1988-09-29 Bissendorf Peptide Gmbh DEVICE FOR REMOVING LOCALLY APPLIED ACTIVE SUBSTANCES AGAINST SOLID TUMORS
US5258503A (en) * 1987-09-08 1993-11-02 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Autoantibody adsorbent and apparatus for removing autoantibodies using the same
US4865841A (en) * 1987-10-23 1989-09-12 Imre Corporation Methods and compositions for transient elimination of humoral immune antibodies
DE3887750T2 (en) 1987-11-20 1994-09-15 Creative Biomolecules Inc SELECTIVE REMOVAL OF IMMUNE COMPLEXES.
WO1989009628A1 (en) * 1988-04-04 1989-10-19 Potempa Lawrence A Binding of immune complexes by modified forms of c-reactive protein
JPH03505287A (en) * 1988-06-20 1991-11-21 イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー Biocompatible, substance-specific reagents for processing physiological fluids
WO1990004416A1 (en) * 1988-10-25 1990-05-03 Invitron Corporation Specific removal of ldl from blood
DE69034042T2 (en) * 1989-08-02 2003-07-17 Mitra Medical Technology Ab Lu SYSTEM FOR USE IN A METHOD FOR THERAPEUTIC AND DIAGNOSTIC TREATMENT
US5196324A (en) * 1989-12-15 1993-03-23 Eli Lilly And Company Monoclonal antibodies reactive with a human atheroma associated antigen
US5187010A (en) * 1990-11-27 1993-02-16 W. R. Grace & Co.-Conn. Membrane having high affinity for low density lipoprotein-cholesterol from whole blood
US5626843A (en) * 1993-02-26 1997-05-06 Advanced Biotherapy Concepts, Inc. Treatment of autoimmune diseases, including AIDS, by removel of interferons, TNFs and receptors therefor
US5753227A (en) 1993-07-23 1998-05-19 Strahilevitz; Meir Extracorporeal affinity adsorption methods for the treatment of atherosclerosis, cancer, degenerative and autoimmune diseases
US6099730A (en) * 1997-11-14 2000-08-08 Massachusetts Institute Of Technology Apparatus for treating whole blood comprising concentric cylinders defining an annulus therebetween

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4375414A (en) * 1971-05-20 1983-03-01 Meir Strahilevitz Immunological methods for removing species from the blood circulatory system and devices therefor
US4813924A (en) * 1971-05-20 1989-03-21 Meir Strahilevitz Immunological methods for removing species from the blood circulatory system
US4612122A (en) * 1981-06-29 1986-09-16 Clara Ambrus Removing heavy metal ions from blood
US4770784A (en) * 1985-11-29 1988-09-13 The Standard Oil Company Scrubbing process for high feed concentrations
US5211850A (en) * 1991-07-26 1993-05-18 Research Medical, Inc. Plasma filter sorbent system for removal of components from blood

Also Published As

Publication number Publication date
US20010039392A1 (en) 2001-11-08
US20020019603A1 (en) 2002-02-14
IL110382A (en) 1998-12-06
US6569112B2 (en) 2003-05-27
US6039946A (en) 2000-03-21
EP0710135B1 (en) 2008-11-26
WO1995003084A2 (en) 1995-02-02
US6676622B2 (en) 2004-01-13
US5753227A (en) 1998-05-19
DE69435170D1 (en) 2009-01-08
US6264623B1 (en) 2001-07-24
AU7472594A (en) 1995-02-20
IL110382A0 (en) 1994-12-29
EP0710135A4 (en) 1997-05-21
US20040220508A1 (en) 2004-11-04
EP0710135A1 (en) 1996-05-08

Similar Documents

Publication Publication Date Title
WO1995003084A3 (en) Extracorporeal affinity adsorption devices
HK1035542A1 (en) Methods for amyloid removal using anti-amyloid antibodies
AU6916296A (en) Recombinant anti-cd4 antibodies for human therapy
MX9709315A (en) Peptides and compounds that bind to a thrombopoietin receptor.
NO913186L (en) PROCEDURE FOR USING AND SYNTHESIS OF PEPTIDES.
ES2132601T3 (en) PROCEDURE FOR THE SELECTION OF SPECIFIC BACTERIOPHAGUSES.
ATE248605T1 (en) CROSS-REACTIVE MONOCLONAL ANTIBODIES SPECIFIC FOR E-SELECTIN AND P-SELECTIN
UA29494C2 (en) Humanized antibodies, methods for producing thereof, a method for treatment of Crohns disease, a method for treatment OF disseminated sclerosis, pharmaceutical composition
MY113497A (en) Peptides and compounds that bind to a receptor
AU696947B2 (en) Monoclonal antibody to oncofetal protein for treating and detecting cancer
NO942850D0 (en)
WO1998025965A3 (en) Peptides and compounds that bind to the thrombopoietin receptor
DE69429925D1 (en) METHOD FOR BINDING MATERIAL TO THE Beta-AMYLOID PEPTIDE
DK0626861T3 (en) Treatment of asthma.
DK1479696T3 (en) Human monoclonal antibody that binds to Ep-CAM and its use in cancer therapy
AU3125289A (en) Monoclonal antibodies directed against human tumor necrosis factor - receptor
FI961083A (en) Recombinant IL4 antibodies useful in the treatment of IL-4-mediated disorders
HU9300538D0 (en) Method for treating endotoxine shock by means of adhesion inhibiting antibodies
AU1716297A (en) Patient-specific immunoadsorbers for the extracorporeal apheresis and methods for their preparation
DE69133484D1 (en) Use of Staphylococcal enterotoxins or related compounds for cancer therapy
ATE270305T1 (en) PEPTIDES OF THE ANTISECRETORIC FACTOR, WHICH REGULATES ILLEGAL CHANGES IN PERMEABILITY
WO2002074251A3 (en) Monoclonal antibody therapy for pancreas cancer
EP2241329A3 (en) Anti-interleukin-9 antibody or anti-interleukin-9 receptor antibody for treating bronchial hyper-responsiveness
MX2021009975A (en) Cd33 antibodies and methods of using the same to treat cancer.
PT840620E (en) IL-8 ANTAGONISTS FOR ASTHMA TREATMENT

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AT AU BB BG BR BY CA CH CN CZ DE DK ES FI GB HU JP KP KR KZ LK LU LV MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AT AU BB BG BR BY CA CH CN CZ DE DK ES FI GB HU JP KP KR KZ LK LU LV MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 08464898

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 1994924465

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1994924465

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA